vancomycin has been researched along with pterostilbene in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Ruvo, CC; Ducret, V; Ebrahimi, SN; Gindro, K; Huber, R; Katanaev, VL; Koval, A; Le Floch, A; Lecoultre, N; Marcourt, L; Michellod, E; Perozzo, R; Perron, K; Queiroz, EF; Righi, D; Rivara-Minten, E; Schnee, S; Wolfender, JL | 1 |
| Xu, Z | 1 |
1 review(s) available for vancomycin and pterostilbene
| Article | Year |
|---|---|
1,2,3-Triazole-containing hybrids with potential antibacterial activity against methicillin-resistant Staphylococcus aureus (MRSA).
Topics: Anti-Bacterial Agents; Drug Design; Methicillin-Resistant Staphylococcus aureus; Triazoles | 2020 |
1 other study(ies) available for vancomycin and pterostilbene
| Article | Year |
|---|---|
Generation of Stilbene Antimicrobials against Multiresistant Strains of
Topics: Anti-Bacterial Agents; Biotransformation; Botrytis; Cell Line; Cell Line, Tumor; Cell Survival; Chromatography, High Pressure Liquid; Drug Resistance, Bacterial; Drug Screening Assays, Antitumor; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Proof of Concept Study; Stilbenes | 2020 |